Amphenol Corporation announced that Prahlad Singh, PhD has been appointed to company's board of directors. With his appointment, the size of the company's board has increased to 10 members. Dr. Singh is currently the President and Chief Executive Officer of PerkinElmer and brings more than twenty-five years of global leadership experience to Amphenol's board.

He was promoted to President and Chief Executive Officer of PerkinElmer effective December 30, 2019, and was appointed to its board of directors in 2019. Prior to his current role, he held various senior executive operating positions within PerkinElmer. Prior to joining PerkinElmer in 2014, Dr. Singh was a General Manager at GE Healthcare, and before that, Dr. Singh held senior executive level roles in strategy, business development and mergers & acquisitions at both GE Healthcare and Philips Healthcare.

Earlier in his career, he held leadership roles of increasing responsibility at DuPont Pharmaceuticals and subsequently at Bristol-Myers Squibb Medical Imaging, which included managing the Asia Pacific and Middle East regions. Dr. Singh holds a doctoral degree in chemistry from the University of Missouri-Columbia and a Master of Business Administration degree from Northeastern University. His research work has resulted in several issued patents and publications in peer reviewed journals.